US 9790220
Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists
granted A61KA61K31/015A61K31/16
Quick answer
US patent 9790220 (Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/015, A61K31/16, A61K31/4439, A61K31/4545